MDCO Stock Chart

MEDICINES CO

 

MDCO

koryu koryu EDIT, W, Long , 2 months ago
EDIT: editas medicine crispr/cas9 investment
483 2 8
EDIT, W Long
editas medicine crispr/cas9 investment
I enter long as long term investment in CRISPR/Cas9 technology. There is still a patent battle going on, thats why there is the big dump in the chart. Buying here feels like catching the knife, so buying slowly over time.
Cryptocol Cryptocol MJNA, D, Long , a month ago
MJNA: MJNA- Poised for the moon
127 0 1
MJNA, D Long
MJNA- Poised for the moon
My first idea here on trading view is probably a controversial one. I am long on MJNA with 2 entry points at 0.04 and 0.182 for a total of approx 6500 shares. MJNA is a stock that is poised for success. Even if only for the next 15-20 days. 9 states have cannabis legalization/medicinal marijuana props on the ...
itradevol itradevol PRO MDCO, W, 2 months ago
MDCO: MDCO Implied Volatility Rising Ahead Of November Trial Results
4 0 1
MDCO, W
MDCO Implied Volatility Rising Ahead Of November Trial Results
MDCO Implied Volatility Rising Ahead Of November Trial Results https://marketchameleon.com/ The Medicines Company  is scheduled to release updated drug trial results for its developmental cardiovascular drug MDCO-216 in November.  Anticipation for the data is beginning to rise, and the stock has already ...
toolbox toolbox PTX, 60, Long , 2 months ago
PTX: $PTX Dust has settled showing genuine opportunity
124 0 1
PTX, 60 Long
$PTX Dust has settled showing genuine opportunity
PTX has been having a bad run over the last year or two. It has been bashed and heavily shorted, the dreaded debt and SEC standards issues added to this. Recently under the new leadership of veteran Sedor, the company has restructured its operations and staffing, added new product in pediatric pain medicine, ...
akyong akyong GOOG, D, Long , 4 months ago
GOOG: Alphabet [Google] Potentially Breaking the All Time High
55 0 1
GOOG, D Long
Alphabet [Google] Potentially Breaking the All Time High
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics. For Verily, the tie-up is the latest sign that Google's desire to move beyond search engines into ...
AcornWealthCorp AcornWealthCorp PRO MDCO, D, Short , 5 months ago
MDCO: MDCO - Short from 33.23
58 0 2
MDCO, D Short
MDCO - Short from 33.23
Upward channel break down in longer frame & formed a pennant now. Money-flow is moving down. We think it will decline around 30 You can check our detailed analysis on MDCO in the trading room/ Executive summery link here- http://www.screencast.com/t/albA50iuLT Time Span: 33:00” Trade Suggestion Date: 5th Jul ...
Pdunuwila Pdunuwila FMI, D, 6 months ago
FMI: Foundation Medicine Inc.
15 0 0
FMI, D
Foundation Medicine Inc.
Demand zone highlighted in yellow at former resistance. Buy on a pullback to the demand zone. Entry: $18.85 Stop Loss: $18.10 Target1: $20.00
andrew.berg andrew.berg PRO LGND, D, Long , 6 months ago
LGND: Ligand Pharmaceuticals best choise in the Biopharma Industry
21 0 2
LGND, D Long
Ligand Pharmaceuticals best choise in the Biopharma Industry
Fundamentals: Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Ligand Pharmaceuticals has a compelling business model that offers higher than average return with lower than ...
KLang KLang PRO MDCO, W, 2 years ago
MDCO: MDCO
98 1 1
MDCO, W
MDCO
Notes on chart
KeeneOnMarket KeeneOnMarket PRO MACK, D, Long , 2 years ago
MACK: Trader Profits 450% Overnight in MACK on Unusual Options Activit
450 0 1
MACK, D Long
Trader Profits 450% Overnight in MACK on Unusual Options Activit
Merrimack Pharmaceuticals, Inc. (MACK) a biopharmaceutical company is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. MACK is currently trading around $7.12 in a 52 week range of $2.05-$7.65. ...
BitcoinMedusa BitcoinMedusa PRO TAN, 60, 2 years ago
TAN: Mentor Tells Me About This Week / via StockMarketMentor
147 0 1
TAN, 60
Mentor Tells Me About This Week / via StockMarketMentor
Here is the ticker list with some notes. Big trendline breaks on many of these. There is no reason to buy, but there is no reason to sell immediately at the open either. The starter pistol fires at 5:30a/est. TAN TF XME IBB XLI XHB XLB MDY IWM OIH XLV XOP XLF SPY XLE IYZ QQQ XLK XLY SMH SDY ...
BitcoinMedusa BitcoinMedusa PRO AAPL, 60, 3 years ago
AAPL: Think Differently Might Be The Right Thing To Do
180 0 0
AAPL, 60
Think Differently Might Be The Right Thing To Do
Break above recent highs, break above prior "w" pattern, and that gap looking like a little piece of history that won't be revisited. This company is a great company period. Progressive, meaningful, well suited for un-expected advances in marketing, medicine, robotics, new communities and no one can out last its ...

News

Fundamentals MDCO

Price History
Average Volume ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Valuation
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Dividends
Dividends Paid ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Margins
After-tax Margin ---
Gross Margin ---
Gross Margin %, TTM ---
Operating Margin ---
Pre-tax Margin ---
Balance Sheet
Cash Ratio ---
Current Ratio ---
Debt to Assets ---
Debt to Equity ---
Long Term Capital ---
Net Debt ---
Quick Ratio ---
Total Assets ---
Total Capital ---
Total Debt ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
EBITDA ---
Gross Profit ---
Last Annual EPS ---
Last Annual Revenue ---
Net Income ---
Total Revenue ---
Operating Metrics
Return on Assets ---
Return on Equity ---
Return on Invested Capital ---
Return on Invested Capital %, TTM ---
Revenue per Employee ---
Market
Interval
Browse
Time
Author
Widgets
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out